CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT SECRETS

Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors inside the central nervous procedure, conolidine modulates alternate molecular targets. A Science Advancements review found that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR